Follow
Dean Wright
Dean Wright
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Synaptopathies: synaptic dysfunction in neurological disorders–A review from students to students
K Lepeta, MV Lourenco, BC Schweitzer, PV Martino Adami, P Banerjee, ...
Journal of neurochemistry 138 (6), 785-805, 2016
3082016
N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease
DJ Wright, T Renoir, ZM Smith, AE Frazier, PS Francis, DR Thorburn, ...
Translational psychiatry 5 (1), e492-e492, 2015
1242015
Analysis of 153 deaths after upper gastrointestinal endoscopy: room for improvement?
AM Thompson, DJ Wright, W Murray, GL Ritchie, HD Burton, ...
Surgical Endoscopy And Other Interventional Techniques 18, 22-25, 2004
1042004
N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington’s disease
DJ Wright, LJ Gray, DI Finkelstein, PJ Crouch, D Pow, TY Pang, S Li, ...
Human molecular genetics 25 (14), 2923-2933, 2016
502016
The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease
X Du, TY Pang, C Mo, T Renoir, DJ Wright, AJ Hannan
Experimental neurology 263, 63-71, 2015
342015
Enhancing permanganate chemiluminescence detection for the determination of glutathione and glutathione disulfide in biological matrices
ZM Smith, JM Terry, NW Barnett, LJ Gray, DJ Wright, PS Francis
Analyst 139 (10), 2416-2422, 2014
252014
Huntington’s Disease: Pathogenic mechanisms and therapeutic targets
DJ Wright, T Renoir, LJ Gray, AJ Hannan
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic …, 2017
102017
Evaluating the attitudes of mental health professionals towards trials of MDMA: a randomised vignette trial
DJ Wright, B Colagiuri, N Glozier
BMJ open 12 (11), e060360, 2022
22022
Implementation of a ketamine programme for treatment-resistant depression in the public health system: Lessons from the first Australian public hospital clinic
NLR Thornton, DJ Wright, N Glozier
Australian & New Zealand Journal of Psychiatry, 00048674241237094, 2024
2024
Die Kraftwerke der Zellen-über die Behandlung von psychiatrischen Symptomen bei Patienten mit Mitochondriopathien
S Mörkl, A Tmava, C Blesl, F Schmiedhofer, WE Wurm, A Holl, A Painold
Fortschritte der Neurologie· Psychiatrie 85 (08), 474-478, 2017
2017
N-ACETYLCYSTEINE (NAC) IN HUNTINGTON’S DISEASE (HD) AND AFFECTIVE-LIKE DISORDERS
D Wright, T Renoir, L Gray, A Hannan
Journal of International Society of Antioxidants in Nutrition & Health 1 (1), 2016
2016
Synaptopathies: synaptic dysfunction in neurological disorders-A review written by students for students
K Lepeta, MV Lourenco, BC Schweitzer, PV Martino Adami, P Banerjee, ...
Wiley Blackwell Publishing, Inc, 2016
2016
Environmental and pharmacological modulation of molecular pathogenesis in Huntington's disease
T Renoir, DJ Wright, LJ Gray, DI Finkelstein, PJ Crouch, D Pow, T Pang, ...
Conference Abstract: 14 th Meeting of the Asian-Pacific Society for …, 2016
2016
The therapeutic effects of N-acetylcysteine in a mouse model of Huntington’s disease
D Wright
University of Melbourne, 2016
2016
Molecular mediators, environmental modulators and gene-environment interactions in huntington's disease
A Hannan, C Mo, D Wright, X Du, T Pang, P Crouch, J Nithianantharajah, ...
Deakin University, 2015
2015
Therapeutic potential of n-acetylcysteine in huntington's disease: effects on glutamate uptake and mitochondrial function in mice
D Wright, T Renoir, D Finkelstein, D Thorburn, P Francis, S McGee, L Gray, ...
Proceedings of the 25th Biennial Meeting of the International Society for …, 2015
2015
CALCULATING THE PROTAMINE HEPARINE REVERSAL RATIO
WB Murray, WA Hampton, H Hargovan, D Wright
The Journal of the American Society of Anesthesiologists 75 (3), A62-A62, 1991
1991
The system can't perform the operation now. Try again later.
Articles 1–17